Upcoming Events
  1. ALTG open MAC and SAC meetings

    November 20
  2. Virtual 2020 World Conference on Lung Cancer Singapore

    January 28, 2021 @ 8:00 am - January 31, 2021 @ 5:00 pm

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

ALTG 15/003 DREAM: A phase II trial of durvalumab with first line chemotherapy in mesothelioma with a safety run in – A Nowak

  • To determine the 6 month PFS, safety and tolerability of durvalumab in combination with cisplatin and pemetrexed in MPM planned for 1st line chemo
  • Planned sample size 54 at approx. 14 sites
  • Protocol finalised and granted central ethics approval
  • First sites opened December 2016
  • There is an initial safety run-in of 6 patients to review any safety issues with the combination
  • Recruitment to this run in was closed in January 2017
  • Recruitment to all sites is due to open mid-late February 2017 once dose has been confirmed
State/TerritorySitePIActivation DateRecruitment
ACTCanberra HospitalDavid Leong
NSWBorder Medical OncologyCraig Underhill
Chris O'Brien LifehouseSteven Kao
Coffs Harbour Health Campus - NCCIKaren Briscoe
Nepean Cancer Care CentreCatherine Crombie
Northern Cancer Institute St LeonardsNick Pavlakis9 Dec 2016
QLDPrincess Alexandra HospitalKen O'Byrne
The Prince Charles HospitalBrett Hughes9 Dec 20162
SAFlinders Medical CentreChris Karapetis
VICAustin HospitalTom John
Peter MacRichard de Boer
WASir Charles Gairdner HospitalAnna Nowak14 Dec 20165
Other (NZ)Auckland HospitalRichard Sullivan
Canterbury Regional Cancer and Haematology ServiceDavid Gibbs

Study Contacts

Study Chair: Anna Nowak     anna.nowak@uwa.edu.au

CTC Trial Coordinator: Hannora Jurcovic     DREAM@ctc.usyd.edu.au